Clinical Observation on Hyperbaric Oxygen-assisted Treatment of Sudden Deafness in Middle-aged and Elderly Patients with Type 2 Diabetes
Objective:To investigate the clinical effect of hyperbaric oxygen-assisted treatment of sudden deafness in middle-aged and elderly patients with type 2 diabetes.Method:A total of 60 middle-aged and elderly patients with sudden deafness with type 2 diabetes treated in the General Medicine Department and Otolaryngology Department of Baoding First Central Hospital from August 2022 to July 2023 were included in this study,they were divided into experimental group(30 cases)and control group(30 cases)according to the random number table method.The control group received glucocorticoid,vascular dilation and nerve nutrition therapies.The experimental group was given HBO therapy on the basis of the control group.After one course of treatment,the pure tone hearing threshold,blood glucose,neutrophil lymphocyte ratio(NLR),platelet lymphocyte ratio(PLR),clinical efficacy,incidences of adverse reactions and complications between the two groups of patients were compared.Result:After treatment,the pure tone hearing thresholds,blood glucose,NLR and PLR in the two groups were lower than those before treatment,and pure tone hearing threshold,blood glucose,NLR and PLR in experimental group were lower than those in control group,the differences were statistically significant(P<0.05).After treatment,the hearing threshold gain of the experimental group was significantly higher than that of the control group,the difference was statistically significant(P<0.05).The total effective rate of the experimental group(86.67%)was significantly higher than that of the control group(60.00%),the difference was statistically significant(P<0.05).There were no significant differences in the incidences of adverse reactions and complications between the two groups(P>0.05).Conclusion:Hyperbaric oxygen-assisted treatment of sudden deafness in middle-aged and elderly patients with type 2 diabetes can reduce the levels of blood glucose and inflammatory factors,improve the clinical therapeutic effect and safety.
Hyperbaric oxygenMiddle-aged and elderlyType 2 diabetesSudden deafness
万方数据
维普
